Career Enhancement Program

职业提升计划

基本信息

批准号：
10226092
负责人：
Scott Kopetz
金额：
$ 24.84万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-20 至 2024-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10226092
关键词：
Academic Training American Association of Cancer Research American Society of Clinical Oncology Area Award Basic Science Budgets Caliber Cancer Biology Cancer Center Clinical Clinical Trials Clinical trial protocol document Colorectal Cancer Country Development Development Plans Diagnosis Disease Early Diagnosis Ensure Feedback Fellowship Financial Support Funding Goals Grant Individual Institutes Institution International Journals Knowledge Laboratories Laboratory Research Lead Leadership Malignant neoplasm of gastrointestinal tract Malignant neoplasm of pancreas Manuscripts Mentors Mentorship Minority Morbidity - disease rate Nature Oncology Pathology Patients Peer Review Physicians Prevention Process Publications Publishing Quality of life Research Research Personnel Research Project Grants Scientist Site Survivors Training Training Programs Translating Translational Research Underrepresented Populations Universities University of Texas M D Anderson Cancer Center Woman Writing anticancer research base cancer diagnosis career career development clinical care design flexibility gastrointestinal improved innovation interest meetings member mortality next generation programs recruit symposium training opportunity translational approach translational research program translational scientist

项目摘要

CAREER ENHANCEMENT PROGRAM: Summary/Abstract The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional young investigators dedicated to translational research in the early detection, prevention, and treatment of pancreatic cancer (PDAC) and colorectal cancer (CRC). Ideally, these investigators will ultimately help to reduce the morbidity and mortality from these diseases. The CEP will extend be available across both participating institutions –MD Anderson and Johns Hopkins University, broadening the scope of expertise and mentorship opportunities available to early career investigators. Underscoring the shared nature of our program, the CEP will be led by Drs. Elizabeth Jaffee at Johns Hopkins and Dr, Scott Kopetz at MD Anderson, respectively. The CEP will A) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of PDAC or CRC B) provide specific knowledge of research in PDAC or CRC that will enhance the ability of awardees to conduct innovative translational science that will directly impact on the understanding and treatment of these diseases; and 3) re-direct individuals who have already shown considerable scientific promise into PDAC or CRC research. To achieve this goal, the SPORE CEP will provide up to five awards of $50,000 each annually for one year, with a competitive option for renewal for an additional year, funded from the SPORE and matching funds from MD Anderson and Johns Hopkins. We will aggressively recruit the most promising young investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee that will provide coaching in grant and manuscript writing, leadership training, networking with PDAC and CRC scholars (including key opinion leaders in concurrently funded SPORE programs around the country), and completing and publishing translational PDAC or CRC related manuscripts in high impact peer reviewed journals. The GI SPORE will utilize multiple programs inside and outside of the Institute to identify outstanding young investigators with an emphasis placed on recruiting qualified women and members of traditionally underrepresented groups. The CEP will also encourage and support awardee presentations at national or international meetings. The ultimate deliverable of our CEP is to train and cultivate the highest caliber of next generation translational research scientists in GI cancers.

职业提升计划：摘要/摘要职业提升计划 (CEP) 的目标是培养训练有素、杰出的年轻人致力于胰腺癌早期检测、预防和治疗转化研究的研究人员理想情况下，这些研究人员最终将有助于减少癌症（PDAC）和结直肠癌（CRC）的发生。这些疾病的发病率和死亡率将扩展到所有参与方。机构——MD安德森大学和约翰霍普金斯大学，扩大专业知识和指导范围为早期职业调查员提供的机会强调了我们的项目 CEP 的共同性质。分别由约翰·霍普金斯大学的 Elizabeth Jaffee 博士和 MD 安德森大学的 Scott Kopetz 博士领导。 CEP 将 A) 招募和培训医生和基础科学家，使他们成为高技能的转化人员 B) PDAC 或 CRC 领域的研究人员提供 PDAC 或 CRC 研究的具体知识，这些知识将提高获奖者进行创新转化科学的能力，这将直接影响了解和治疗这些疾病；3) 重新指导已经表现出症状的个体为了实现这一目标，SPORE CEP 将为 PDAC 或 CRC 研究提供巨大的科学前景。一年内每年最多可获得 5 个奖项，每个奖项各 50,000 美元，并可提供竞争性续订选项今年，我们将积极开展 SPORE 资助以及 MD 安德森和约翰霍普金斯大学的配套资金。招募最有前途的年轻研究者，并制定个性化的临床和临床发展计划实验室导师和指导委员会将提供资助和手稿写作方面的指导，领导力培训、与 PDAC 和 CRC 学者（包括同时担任的关键意见领袖）建立联系资助全国各地的 SPORE 项目），并完成并出版 PDAC 或 CRC 相关的翻译成果高影响力同行评审期刊上的手稿将在 GI SPORE 内部使用多个程序。院外遴选优秀青年科研人员，重点招聘合格人才 CEP 还将鼓励和支持妇女和传统上代表性不足的群体成员。获奖者在国内或国际会议上的演讲我们的 CEP 的最终成果是培训和培训。培养胃肠道癌症领域最高水平的下一代转化研究科学家。